Blanca Ledezma, NP
Articles
The Impact of Molecular Testing on Treatment Choices for NSCLC
Rajat Thawani, MD, MBBs ;Edward S. Kim, MD, MBA;Edward B. Garon, MD, MS ;Katherine Cunha, NP ;Blanca Ledezma, NP
December 23rd 2024A discussion with Dr. Garon highlights patient selection for EGFR inhibitor therapy in EGFR+ NSCLC, emphasizing the critical role of biomarker testing, testing approaches, and overcoming barriers in community settings.
Robert’s Journey With EGFR+ Metastatic NSCLC
Rajat Thawani, MD, MBBs ;Edward S. Kim, MD, MBA;Edward B. Garon, MD, MS ;Katherine Cunha, NP ;Blanca Ledezma, NP
December 23rd 2024The video segment profiles a 58-year-old retired construction manager with Stage IV EGFR+ NSCLC, discussing his transition from osimertinib to amivantamab plus chemotherapy, managing side effects, and maintaining hope throughout his treatment journey.
Latest Updated Articles
Published: September 13th 2024 | Updated: November 25th 2024
Non–clear Cell RCC: First-Line Treatment Options and Guideline Updates
Published: August 9th 2024 | Updated: August 14th 2024
Gene Assay May Predict Extended Letrozole Benefits in Breast Cancer Subsets
Published: June 2nd 2024 | Updated: June 3rd 2024
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Published: May 6th 2024 | Updated: May 21st 2024
FDA Accepts BLA for Subcutaneous Nivolumab in Solid Tumor Indications
Published: July 31st 2012 | Updated: December 25th 2024
NSCLC Patient Develops Fever and Rash Following Treatment for Brain Metastases
Published: August 26th 2011 | Updated: December 25th 2024
Patient With Supraglottic Squamous Cell Carcinoma Develops Painful Swelling on Both Great Toes
